See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-104. Impact of Aortic Root Calcification Volume on Clinical Outcomes After Transcatheter Aortic Valve Implantation

Presenter: Yusuke Watanabe

October 29, 2013

Presentation TCT 2013

TCT-10. Differences Between US and non-US Cohorts after PCI and Dual Antiplatelet Therapy: Patient Characteristics, Randomization

Presenter: Laura Mauri

October 29, 2013

Presentation TCT 2013

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

Presenter: Vivek Reddy

October 29, 2013

Presentation TCT 2013

TCT-75. Novel Fully-Quantitative Virtual Histology Analysis of Confluent Necrotic Core Size and Fibrous Cap Thickness in Relation to Conventional Phenotypic Plaque Type Assessme...

Presenter: Piotr Musialek

October 29, 2013

Presentation

Case 4: Patient with Atrial Fibrillation and DES

Presenter: Roxana Mehran

October 29, 2013

Presentation TCT 2013

Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery

Presenter: Masato Nakamura

October 29, 2013

Presentation TCT 2013

Update on ADSCs and MPCs for STEMI

Presenter: Henricus Duckers

October 29, 2013

Presentation TCT 2013

Cell Therapy for Chronic Advanced Posinfarction Remodeling. Is there a Role?

Presenter: Francisco Fdez-Aviles

October 29, 2013

$Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO$

Presentation TCT 2013

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

Presenter: Timothy Henry

October 29, 2013

Presentation TCT 2013

Which patients are still having PCI via the Femoral approach in centres that are default Radial centres? Results and Insights from a single centre experience

Presenter: Muezz Uddin

October 29, 2013

Advertisement

Slides

TCT-104. Impact of Aortic Root Calcification Volume on Clinical Outcomes After Transcatheter Aortic Valve Implantation

TCT-10. Differences Between US and non-US Cohorts after PCI and Dual Antiplatelet Therapy: Patient Characteristics, Randomization

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

TCT-75. Novel Fully-Quantitative Virtual Histology Analysis of Confluent Necrotic Core Size and Fibrous Cap Thickness in Relation to Conventional Phenotypic Plaque Type Assessme...

Case 4: Patient with Atrial Fibrillation and DES

Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery

Update on ADSCs and MPCs for STEMI

Cell Therapy for Chronic Advanced Posinfarction Remodeling. Is there a Role?

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

Which patients are still having PCI via the Femoral approach in centres that are default Radial centres? Results and Insights from a single centre experience

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content